Chemomab Therapeutics Ltd. (NASDAQ:CMMB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gwen Melincoff Other companies: Gain Therapeutics, Inc. (Independent Member · Since at least Mar 17, 2021); Protalix BioTherapeutics, Inc. (de) (Director · Since at least Jan 1, 2020); Soleno Therapeutics, Inc. (Director · Apr 26, 2019 – May 25, 2023 · Past); Collegium Pharmaceutical, Inc. (Director · Aug 9, 2017 – May 16, 2024 · Past); Tobira Therapeutics Inc (Director · May 4, 2015 – Nov 1, 2016 · Past) | Board Director · Since at least Jun 1, 2026 |
| Stephen J DiPalma Other companies: Inozyme Pharma Inc (Interim CFO · May 17, 2021 – May 17, 2021 · Past); Solid Biosciences Inc. (Interim CFO · Jan 29, 2021 – Jan 29, 2021 · Past); Generation Bio Co (See Remarks · Jun 11, 2020 – Jun 11, 2020 · Past); Spero Therapeutics, Inc. (See Remarks · Nov 8, 2019 – Jul 15, 2023 · Past); Interleukin Genetics Inc (Interim CFO · Jul 29, 2016 – Jul 29, 2016 · Past) | Chief Financial Officer · May 1, 2020 – May 1, 2020 · Past |
| Ruth Alon Other companies: Alpha Tau Medical Ltd (Director · Since at least Mar 18, 2026); Silexion Therapeutics Corp (Director · Since at least Aug 15, 2024); Vascular Biogenics Ltd (Director · Jan 1, 2023 – Jan 1, 2023 · Past); Moringa Acquisition Corp (Director · Feb 16, 2021 – Feb 16, 2021 · Past) | Director · Jan 1, 2020 – Jan 1, 2020 · Past |
| Claude Nicaise Other companies: Filana Therapeutics, Inc. (Independent Director, Chairman of the Board · Since at least Dec 6, 2023); Gain Therapeutics, Inc. (Independent Member · Since at least Mar 17, 2021); Sarepta Therapeutics, Inc. (Director · Since at least Jun 2, 2015) | Board Director · Since at least Mar 16, 2021 |
| Jill Quigley Other companies: Filana Therapeutics, Inc. (Director · Since at least Nov 11, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 4, 2021); Passage Bio, Inc. (Chief Operating Officer · Feb 27, 2020 – Dec 8, 2021 · Past) | Board Director · Since at least Jun 16, 2022 |
| Alan Moses Other companies: BiomX Inc. (Director · Oct 2, 2020 – Apr 14, 2025 · Past) | Board Director · Since at least Mar 16, 2021 |
| Isaac T. Kohlberg Other companies: Acacia Research Corporation (Director · Since at least May 6, 2019) | Director · Jan 1, 2020 – Jan 1, 2020 · Past |
| Reginald L Hardy Other companies: Brickell Biotech Inc (CHAIRMAN OF THE BOARD, Director · Aug 31, 2019 – May 17, 2022 · Past) | Director · Jan 1, 2020 – Jan 1, 2020 · Past |
| Adi Mor | Co-Founder, Chief Executive Officer and Chief Scientific Officer · Since at least Nov 5, 2026 |
| Andrew Fine | Chief Financial Officer · Oct 20, 2020 – Oct 20, 2020 · Past |
| Arnon Aharon | Chief Medical Officer · Mar 16, 2021 – Mar 16, 2021 · Past |
| Barbara Lindheim | Consulting Vice President, Strategic Communications, Investor & Public Relations · Since at least Nov 2, 2026 |
| David Weiner | Interim Chief Medical Officer · Since at least Nov 4, 2026 |
| Donald Marvin | Executive VP, CFO & COO · Nov 8, 2021 – Mar 16, 2022 · Past |
| George Adi Mor | Chief Executive Officer, Director · Since at least Mar 16, 2021 |
| Jack Lawler | Chief Development Officer · Since at least Nov 4, 2026 |
| John Lawler | Chief Development Officer · Since at least Mar 18, 2026 |
| Matthew Bejosa Frankel | Chief Medical Officer · Nov 14, 2022 – Nov 14, 2022 · Past |
| Neil Cohen | Board Director · Since at least Apr 23, 2020 |
| Nissim Darvish | Director · Since at least Mar 16, 2021 |
| Revital Aricha | Vice President, Translational Science · Since at least Nov 4, 2026 |
| Ron Knickerbocker | See Remarks · Jan 1, 2020 – Jan 1, 2020 · Past |
| Salar Roshan | Head of Business Development · Jan 1, 2020 – Jan 1, 2020 · Past |
| Sigal Fatal | Chief Financial Officer · Since at least Mar 18, 2026 |
| Sigal Fattal | Chief Financial Officer · Since at least Nov 4, 2026 |
| Stanislav Polovets | Director · Apr 23, 2020 – Apr 23, 2020 · Past |